Evidence map›Paper›PMID 33268339›Full record

ArticleBMJ open respiratory research2020

Endotypes identified by cluster analysis in asthmatics and non-asthmatics and their clinical characteristics at follow-up: the case-control EGEA study.

Rachel Nadif, Mickael Febrissy, Miora Valérie Andrianjafimasy, Nicole Le Moual, Frederic Gormand, Jocelyne Just, Isabelle Pin, Valerie Siroux, Régis Matran, Orianne Dumas and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open respiratory research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. One march, many paths: Insights into allergic march trajectories.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Rachel NadifUniversité Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM, Equipe d'Epidémiologie Respiratoire Intégrative, CESP, 94807 Villejuif, France rachel.nadif@inserm.fr.ORCID 0000-0003-4938-9339
Mickael FebrissyUniversité de Paris, LIPADE, Paris, France.
Miora Valérie AndrianjafimasyUniversité Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM, Equipe d'Epidémiologie Respiratoire Intégrative, CESP, 94807 Villejuif, France.ORCID 0000-0002-5791-0772
Nicole Le MoualUniversité Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM, Equipe d'Epidémiologie Respiratoire Intégrative, CESP, 94807 Villejuif, France.
Frederic GormandCHU de Lyon, Pneumology Department, Lyon, France.
Jocelyne JustService d'Allergologie, APHP, Hôpital Trousseau, Sorbonne Université, Paris, France.
Isabelle PinUniv. Grenoble Alpes, INSERM, CNRS, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, IAB, 38000 Grenoble, France.
Valerie SirouxUniv. Grenoble Alpes, INSERM, CNRS, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, IAB, 38000 Grenoble, France.
Régis MatranUniversité de Lille Nord de France, Lille, France.
Orianne DumasUniversité Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM, Equipe d'Epidémiologie Respiratoire Intégrative, CESP, 94807 Villejuif, France.ORCID 0000-0001-8423-2826
Mohamed NadifUniversité de Paris, CNRS, Centre Borelli, 75005 Paris, France.
Université Paris-Sud · FRCentre National de la Recherche Scientifique · FRHôpital Lyon Sud · FRSorbonne Université · FRUniversité de Lille · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdentifying relevant asthma endotypes may be the first step towards improving asthma management. We aimed identifying respiratory endotypes in adults using a cluster analysis and to compare their clinical characteristics at follow-up.

methodsThe analysis was performed separately among current asthmatics (CA, n=402) and never asthmatics (NA, n=666) from the first follow-up of the French EGEA study (EGEA2). Cluster analysis jointly considered 4 demographic, 22 clinical/functional (respiratory symptoms, asthma treatments, lung function) and four blood biological (allergy-related, inflammation-related and oxidative stress-related biomarkers) characteristics at EGEA2. The clinical characteristics at follow-up (EGEA3) were compared according to the endotype identified at EGEA2.

resultsWe identified five respiratory endotypes, three among CA and two among NA: CA1 (n=53) with active treated adult-onset asthma, poor lung function, chronic cough and phlegm and dyspnoea, high body mass index, and high blood neutrophil count and fluorescent oxidation products level; CA2 (n=219) with mild asthma and rhinitis; CA3 (n=130) with inactive/mild untreated allergic childhood-onset asthma, high frequency of current smokers and low frequency of attacks of breathlessness at rest, and high IgE level; NA1 (n=489) asymptomatic, and NA2 (n=177) with respiratory symptoms, high blood neutrophil and eosinophil counts. CA1 had poor asthma control and high leptin level, CA2 had hyper-responsiveness and high interleukin (IL)-1Ra, IL-5, IL-7, IL-8, IL-10, IL-13 and TNF-α levels, and NA2 had high leptin and C reactive protein levels. Ten years later, asthmatics in CA1 had worse clinical characteristics whereas those in CA3 had better respiratory outcomes than CA2; NA in NA2 had more respiratory symptoms and higher rate of incident asthma than those in NA1.

conclusionThese results highlight the interest to jointly consider clinical and biological characteristics in cluster analyses to identify endotypes among adults with or without asthma.

Indexed as

AsthmaRhinitisAdultCase-Control StudiesChildCluster AnalysisHumansLeukocyte Countasthma epidemiology

Identifiers

PMID33268339
PMCPMC7713177
OpenAlexW3108261366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.